Do TREM2 activation states define distinct amyloid clearance thresholds requiring personalized dosing strategies?

immunology open composite 70%
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
70%
Novelty
80%
Mechanistic
—
Druggability
—
Priority
79%
Importance
88%
Tractability
75%
Market price
50%

Description

The debate introduced TREM2-dependent microglial transitions as threshold determinants but left the mechanistic details and clinical implications unresolved. This could explain patient-to-patient variability in treatment response.

Source: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-192526-f2bbb9ab_20260416-135142 (Analysis: SDA-2026-04-16-gap-pubmed-20260410-192526-f2bbb9ab)